4.0
Jan 14, 2021
Anonymous employee
Current employee, more than 1 year
Berlin
Recommend
CEO approval
Business outlook
Pros
Bayer's ambition is to remain a big, innovative player in the pharmaceutical industry. The company is currently going through a major transition by acquiring smaller, very promising biotech companies and divesting older business/products. This puts Bayer right on track and will strengthen the product pipeline/portfolio for the next years.
Cons
Historically, Bayer is regarded as a very conservative company with "old", un-innovative men running the business. In part, this is still the case, even though I see constant improvement. Change needs time in a big company like Bayer